Once daily treatment with Denali's oral candidate DNL343 failed to reduce NfL levels in adults with ALS in the HEALEY trial.

Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...

ALS, which is also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — the nerve cells ...

Neurologists have grappled with a cluster of amyotrophic lateral sclerosis cases in France, where a fondness for a toxic wild ...

Scientists have developed a breakthrough technique to directly convert skin cells into neurons, bypassing the need for stem ...

They also confirmed that graphene quantum dots protect nerve cells in mutation models of other causative proteins of ALS, such as FUS and C9orf72. This suggests that graphene quantum dots can ...

People with ALS have three times higher blood levels of neurofilament light chain proteins, which are produced when nerve cells are injured or die, than people with other brain diseases, researchers ...

People with ALS have three times higher blood levels of neurofilament light chain proteins, which are produced when nerve cells are injured or die, than people with other brain diseases ...

ALS Walk in Elbow is on the Horizon and registration is finally open. On Sunday, June 8, the walk starts from the Elbow ...

A new study compares three types of blood biomarkers: neurofilament light chain proteins, glial acidic proteins and ...

ALS affects nerve cells in the brain and spinal cord and progressively gets worse over time. This causes muscle control problems such as weakness in the limbs and slurred speech. As the disease ...